SCHEMBL29914192

SCHEMBL29914192

CC1(C)CC2(CC(C)(C)c3cc(O)ccc32)c2ccc(O)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 10/20 0.39
CYP3A4 P08684 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
OPRD1 P41143 6/20 0.38
OPRK1 P41145 5/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
MRGPRX2 Q96LB1 2/20 0.36
KDM4E B2RXH2 2/20 0.35
TP53 P04637 2/20 0.35
ALOX15 P16050 2/20 0.35
MTOR P42345 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
THPO P40225 1/20 0.35
HIF1A Q16665 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL237708 1.00 OPRM1 (0.39) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL29900519 0.96 OPRM1 (0.37) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL3264817 0.96 OPRM1 (0.37) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL2003721 0.96 OPRM1 (0.37) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL169731 0.92 OPRM1 (0.39) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL29401440 0.92 OPRM1 (0.39) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL9328056 0.89 OPRM1 (0.35) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL18415542 0.89 MAPT (0.39) OPRM1CYP3A4ALDH1A1LMNAOPRD1
SCHEMBL9721391 0.87 OPRM1 (0.41) OPRM1CYP3A4ALDH1A1LMNAOPRD1
Bicarbonate SCHEMBL7804013 0.85 CYP3A4 (0.41) OPRM1CYP3A4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures COVESTRO DEUTSCHLAND AG (DE) 2026-04-14 US disclosed
EP-4549163-A2 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2025-05-07 EP disclosed
EP-4493388-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-01-22 EP disclosed
EP-4448279-A1 AT LEAST PARTIALLY BIOBASED LAYERED STRUCTURE WITH GOOD FAVOURABLE PROPERTIES Covestro Deutschland AG (DE) 2024-10-23 EP disclosed
US-20240308191-A1 SPECIAL POLYMER LAYERS FOR FASTER LAMINABILITY OF MULTILAYER STRUCTURES COVESTRO DEUTSCHLAND AG (DE) 2024-09-19 US disclosed
WO-2023174814-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2023-09-21 WO disclosed
WO-2023110961-A1 AT LEAST PARTIALLY BIOBASED LAYERED STRUCTURE WITH GOOD FAVOURABLE PROPERTIES COVESTRO DEUTSCHLAND AG (DE) 2023-06-22 WO disclosed
EP-4197783-A1 AT LEAST PARTIALLY BIOBASED LAYERED STRUCTURE WITH GOOD FLAME RESISTANCE Covestro Deutschland AG (DE) 2023-06-21 EP disclosed
EP-4119344-A1 SPECIAL POLYMER LAYERS FOR FASTER LAMINATION OF MULTILAYER STRUCTURES Covestro Deutschland AG (DE) 2023-01-18 EP disclosed
EP-3727851-B1 PLASTIC FILMS FOR ID DOCUMENTS WITH IMPRINTED HOLOGRAMS HAVING IMPROVED BRIGHTNESS COVESTRO DEUTSCHLAND AG (DE) 2023-01-04 EP disclosed
EP-3645297-B1 IMPROVED METHOD FOR THE PARTIAL COLOURING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2022-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures ASH2L, SMC2, ELL OPRM1 3517/4885CYP3A4 4658/4885ALDH1A1 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.